Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis

To assess safety and efficacy of AL-15469A 0.5% /AL-6515 0.3% Ophthalmic Suspension for treatment of bacterial conjunctivitis

Inclusion Criteria:

• Male and female patients of any race
• 5 years of age and older at the time of the Day 1 visit
• with a primary clinical diagnosis of bacterial conjunctivitis.

Exclusion Criteria:

• Onset of bacterial conjunctivitis (signs and symptoms) more than 4 days
• Presence of punctal plug or punctal occlusion
• Visual Acuity worse than 20/80
• Upper respiratory infection